Metraipolis › archive › dc_2cd99d2384bd

Post Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in… — Europe PMC PMID:41954657

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41954657
DOI: 10.1158/1078-0432.ccr-25-4702
License (as archived): solo-consultazione
Archived: 2026-10-18T14:08:42.926Z
SHA-256 of the archived text: f47c429d770857a5090fbd1e86cc2a386639ad834f024f62b9ec8240c8493fe2
Stable URL of this page: https://metraipolis.com/documento/dc_2cd99d2384bd

How to cite

Post Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in… — Europe PMC PMID:41954657 — Europe PMC (en), https://europepmc.org/article/MED/41954657 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2cd99d2384bd (Metraipolis archive dc_2cd99d2384bd, sha256 f47c429d770857a5090fbd1e86cc2a386639ad834f024f62b9ec8240c8493fe2)

BibTeX

@misc{dc2cd99d2384bd,
  title = {Post Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in… — Europe PMC PMID:41954657},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41954657},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2cd99d2384bd; sha256 f47c429d770857a5090fbd1e86cc2a386639ad834f024f62b9ec8240c8493fe2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41954657. Agents can read the archived copy with the MCP tool read_document.